SynthesisJAMA oncology2018

Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis.

Adam J Waxman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.